VOYA Investment Management
SUPN icon

VOYA Investment Management’s Supernus Pharmaceuticals SUPN Stock Holding History

VOYA Investment Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.64M Sell
31,748
-1,566
-5% -$79.7K ﹤0.01% 1270
2025
Q4 		$1.66M Sell
33,314
-14,299
-30% -$695K ﹤0.01% 1291
2025
Q3 		$2.28M Sell
47,613
-12,101
-20% -$487K ﹤0.01% 1181
2025
Q2 		$1.88M Buy
59,714
+120
+0.2% +$3.85K ﹤0.01% 1332
2025
Q1 		$1.95M Buy
59,594
+16,786
+39% +$595K ﹤0.01% 1318
2024
Q4 		$1.55M Sell
42,808
-1,522
-3% -$53.6K ﹤0.01% 1402
2024
Q3 		$1.38M Sell
44,330
-447
-1% -$14K ﹤0.01% 1472
2024
Q2 		$1.2M Sell
44,777
-629
-1% -$18.2K ﹤0.01% 1533
2024
Q1 		$1.55M Sell
45,406
-77,081
-63% -$2.29M ﹤0.01% 1441
2023
Q4 		$3.54M Buy
122,487
+75,546
+161% +$2M ﹤0.01% 1135
2023
Q3 		$1.29M Buy
46,941
+227
+0.5% +$6.91K ﹤0.01% 1506
2023
Q2 		$1.4M Buy
46,714
+417
+0.9% +$14.6K ﹤0.01% 1499
2023
Q1 		$1.68M Sell
46,297
-20
-0% -$769 ﹤0.01% 1427
2022
Q4 		$1.65M Hold
46,317
– – ﹤0.01% 1409
2022
Q3 		$1.57M Sell
46,317
-4,826
-9% -$157K ﹤0.01% 1426
2022
Q2 		$1.48M Sell
51,143
-712
-1% -$20.4K ﹤0.01% 1225
2022
Q1 		$1.68M Buy
51,855
+348
+0.7% +$10.7K ﹤0.01% 1201
2021
Q4 		$1.5M Buy
51,507
+15,047
+41% +$457K ﹤0.01% 1304
2021
Q3 		$972K Sell
36,460
-16
-0% -$429 ﹤0.01% 1588
2021
Q2 		$1.12M Sell
36,476
-1,853
-5% -$56.8K ﹤0.01% 1559
2021
Q1 		$1M Buy
38,329
+6,959
+22% +$195K ﹤0.01% 1584
2020
Q4 		$789K Buy
31,370
+4,501
+17% +$96.9K ﹤0.01% 1638
2020
Q3 		$560K Sell
26,869
-14,682
-35% -$333K ﹤0.01% 1604
2020
Q2 		$987K Sell
41,551
-7,580
-15% -$167K ﹤0.01% 1274
2020
Q1 		$884K Buy
49,131
+763
+2% +$16K ﹤0.01% 1290
2019
Q4 		$1.15M Sell
48,368
-235,942
-83% -$5.73M ﹤0.01% 1376
2019
Q3 		$7.81M Sell
284,310
-67,625
-19% -$2M 0.02% 671
2019
Q2 		$11.6M Sell
351,935
-151,897
-30% -$5.2M 0.03% 555
2019
Q1 		$17.7M Sell
503,832
-160,119
-24% -$5.96M 0.04% 410
2018
Q4 		$22.1M Buy
663,951
+3,545
+0.5% +$152K 0.05% 326
2018
Q3 		$33.3M Buy
660,406
+75,087
+13% +$3.71M 0.07% 292
2018
Q2 		$35M Buy
585,319
+528,685
+934% +$27.4M 0.07% 280
2018
Q1 		$2.59M Hold
56,634
– – 0.01% 969
2017
Q4 		$2.26M Sell
56,634
-8,722
-13% -$345K ﹤0.01% 1013
2017
Q3 		$2.61M Sell
65,356
-5,942
-8% -$257K 0.01% 965
2017
Q2 		$3.07M Sell
71,298
-17,895
-20% -$637K 0.01% 913
2017
Q1 		$2.79M Buy
89,193
+39,837
+81% +$1.07M 0.01% 941
2016
Q4 		$1.25M Buy
49,356
+28,925
+142% +$646K ﹤0.01% 1219
2016
Q3 		$505 Hold
20,431
– – ﹤0.01% 1723
2016
Q2 		$416K Sell
20,431
-25,788
-56% -$457K ﹤0.01% 1824
2016
Q1 		$705K Buy
46,219
+20,616
+81% +$269K ﹤0.01% 1484
2015
Q4 		$344K Buy
25,603
+9,654
+61% +$149K ﹤0.01% 1967
2015
Q3 		$224K Sell
15,949
-4,359
-21% -$81.1K ﹤0.01% 2214
2015
Q2 		$345K Hold
20,308
– – ﹤0.01% 2170
2015
Q1 		$246K Hold
20,308
– – ﹤0.01% 2353
2014
Q4 		$169K Hold
20,308
– – ﹤0.01% 2520
2014
Q3 		$176K Hold
20,308
– – ﹤0.01% 2522
2014
Q2 		$222K Buy
+20,308
New +$181K ﹤0.01% 2521

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VOYA Investment Management's SUPN Position: Q1 2026 in Review

VOYA Investment Management reduced its Supernus Pharmaceuticals (SUPN) stake by 4.7% in Q1 2026, selling an estimated $79.7K and leaving 31,748 shares worth $1.64M. The position accounts for ﹤0.01% of the portfolio, ranked #1270.

VOYA Investment Management first reported a position in SUPN in Q2 2014 and has held it in 48 quarters since. The position peaked at $35M in Q2 2018. 327 funds tracked by Wall St. Rank hold SUPN as of Q1 2026.

  • VOYA Investment Management held 31,748 shares of Supernus Pharmaceuticals worth $1.64M as of Q1 2026.
  • VOYA Investment Management sold 1,566 Supernus Pharmaceuticals shares in Q1 2026, an estimated $79.7K.
  • Supernus Pharmaceuticals made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #1270 holding.
  • VOYA Investment Management first reported a position in Supernus Pharmaceuticals in Q2 2014 and has held it in 48 quarters since.
  • VOYA Investment Management's Supernus Pharmaceuticals position peaked at $35M in Q2 2018.
  • 327 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.